AR and cancer: Such a mechanism underscores the complex interplay between hormonal signaling and epigenetic modifiers in cancer progression, where ING1 and ING2 emerge as critical mediators of AR’s transcriptional repressive functions on key oncogenic drivers (Bartsch et al., 2021).